an increasing trendp = 0.079
The NP Moraxella EC showed an increasing trend between baseline and Week-2 in the oral suspension group (0.25, −0.03 to 0.53, p = 0.079).
The NP Moraxella EC showed an increasing trend between baseline and Week-2 in the oral suspension group (0.25, −0.03 to 0.53, p = 0.079).